UniSuper Management’s Biogen BIIB Stock Holding History

UniSuper Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.61M	Buy	16,729 +1,157	+7%	+$221K	0.02%	344
2026 Q1	$2.85M	Sell	15,572 -855	-5%	-$158K	0.02%	378
2025 Q4	$2.89M	Sell	16,427 -3,574	-18%	-$584K	0.02%	385
2025 Q3	$2.8M	Buy	20,001 +1,588	+9%	+$215K	0.02%	421
2025 Q2	$2.31M	Buy	18,413 +742	+4%	+$92.5K	0.02%	435
2025 Q1	$2.42M	Buy	17,671 +1,186	+7%	+$170K	0.02%	409
2024 Q4	$2.52M	Sell	16,485 -42,345	-72%	-$7.14M	0.02%	385
2024 Q3	$11.4M	Buy	58,830 +1,738	+3%	+$364K	0.09%	155
2024 Q2	$13.2M	Buy	57,092 +4,203	+8%	+$913K	0.11%	128
2024 Q1	$11.4M	Buy	52,889 +4,671	+10%	+$1.09M	0.11%	130
2023 Q4	$12.5M	Sell	48,218 -854	-2%	-$210K	0.14%	117
2023 Q3	$12.6M	Sell	49,072 -15,026	-23%	-$4.02M	0.15%	110
2023 Q2	$18.3M	Buy	+64,098	New	+$19.1M	0.21%	98

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UniSuper Management's BIIB Position: Q2 2026 in Review

UniSuper Management increased its Biogen (BIIB) stake by 7.4% in Q2 2026, buying an estimated $221K and bringing the position to 16,729 shares worth $3.61M. The position accounts for 0.02% of the portfolio, ranked #344.

UniSuper Management first reported a position in BIIB in Q2 2023 and has held it in 13 quarters since. The position peaked at $18.3M in Q2 2023. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

UniSuper Management held 16,729 shares of Biogen worth $3.61M as of Q2 2026.
UniSuper Management bought 1,157 Biogen shares in Q2 2026, an estimated $221K.
Biogen made up 0.02% of UniSuper Management's portfolio in Q2 2026, its #344 holding.
UniSuper Management first reported a position in Biogen in Q2 2023 and has held it in 13 quarters since.
UniSuper Management's Biogen position peaked at $18.3M in Q2 2023.
1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on UniSuper Management's 13F filing for Q2 2026, filed 14 Aug 2026.